Monash gets grants
April 30, 2014
Monash University’s Institute
of Pharmaceutical Science, Faculty
of Medicine, Nursing and Health
Sciences and the PHI-Monash
Institute of Medical Research have
received two grants from the US
National Institute of Health, worth
$10m, to develop treatments for
infections caused by antibiotic
resistant bacteria.
The international team would
focus on new therapies, which
was important given the decline
in discovery of new antibiotics,
Monash University said.
This was a significant public health
problem, Fulbright scholar Suzanne
Schultz has said (PD 13 Mar).
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 14